Cargando…
Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling
In this study, we investigated the mechanism by which tomentodione M (TTM), a novel natural syncarpic acid-conjugated monoterpene, reversed multi-drug resistance (MDR) in cancer cells. TTM increased the cytotoxicity of chemotherapeutic drugs such as docetaxel and doxorubicin in MCF-7/MDR and K562/MD...
Autores principales: | Zhou, Xu-Wei, Xia, Yuan-Zheng, Zhang, Ya-Long, Luo, Jian-Guang, Han, Chao, Zhang, Hao, Zhang, Chao, Yang, Lei, Kong, Ling-Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731928/ https://www.ncbi.nlm.nih.gov/pubmed/29254218 http://dx.doi.org/10.18632/oncotarget.21949 |
Ejemplares similares
-
p38 MAPK in MDS
por: Gañán‐Gómez, Irene, et al.
Publicado: (2015) -
Inhibition of p38 MAPK diminishes doxorubicin-induced drug resistance associated with P-glycoprotein in human leukemia K562 cells
por: Chen, Yinghui, et al.
Publicado: (2012) -
Inhibition of p38 MAPK regulates epileptic severity by decreasing expression levels of A1R and ENT1
por: Zhou, Xuejiao, et al.
Publicado: (2020) -
New Insights into the p38γ and p38δ MAPK Pathways
por: Risco, Ana, et al.
Publicado: (2012) -
Hydrazinocurcumin Induces Apoptosis of Hepatocellular Carcinoma Cells Through the p38 MAPK Pathway
por: He, Hongtao, et al.
Publicado: (2020)